These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31464243)

  • 1. Predictive values of dyslipidemia and B-type natriuretic peptide levels in juvenile systemic lupus erythematosus: A two center-experience.
    El-Gamasy MA; Abd Elsalam MM; Abd-El Latif AM; Elsaid HH
    Saudi J Kidney Dis Transpl; 2019; 30(4):863-872. PubMed ID: 31464243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-type natriuretic peptide (BNP) levels in female systemic lupus erythematosus patients: what is the clinical significance?
    Karadag O; Calguneri M; Yavuz B; Atalar E; Akdogan A; Kalyoncu U; Kiraz S; Aksoyek S; Ozmen F; Ertenli AI
    Clin Rheumatol; 2007 Oct; 26(10):1701-4. PubMed ID: 17318274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyslipidemia in patients with systemic lupus erythematosus: Association with disease activity and B-type natriuretic peptide levels.
    Yuan J; Li LI; Wang Z; Song W; Zhang Z
    Biomed Rep; 2016 Jan; 4(1):68-72. PubMed ID: 26870337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipidemia in pediatric systemic lupus erythematosus: the relationship with disease activity and plasma homocysteine and cysteine concentrations.
    Ortiz TT; Terreri MT; Caetano M; Souza FS; D'Almeida V; Sarni RO; Hilário MO
    Ann Nutr Metab; 2013; 63(1-2):77-82. PubMed ID: 23942034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory aspects of dyslipidemia in Brazilian women with systemic lupus erythematosus.
    Atta AM; Silva JPCG; Santiago MB; Oliveira IS; Oliveira RC; Sousa Atta MLB
    Clin Rheumatol; 2018 Jun; 37(6):1539-1546. PubMed ID: 29516281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for cardiovascular disease in systemic lupus erythematosus.
    Svenungsson E; Jensen-Urstad K; Heimbürger M; Silveira A; Hamsten A; de Faire U; Witztum JL; Frostegård J
    Circulation; 2001 Oct; 104(16):1887-93. PubMed ID: 11602489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of traditional cardiovascular risk factors in patients with systemic lupus erythematosus].
    Liu L; Zhang T; Ye Y; Zhang S; Chen L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Sep; 42(9):753-8. PubMed ID: 25511096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk of heart failure in systemic lupus erythematosus.
    Kim CH; Al-Kindi SG; Jandali B; Askari AD; Zacharias M; Oliveira GH
    Heart; 2017 Feb; 103(3):227-233. PubMed ID: 27613169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass and atherogenic dyslipidemia as major determinants of blood levels of B-type natriuretic peptides in Arab subjects with acute coronary syndromes.
    Akanji AO; Suresh CG; Al-Radwan R; Fatania HR
    Metab Syndr Relat Disord; 2009 Dec; 7(6):563-9. PubMed ID: 19642911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of rituximab on the lipid profile of patients with active systemic lupus erythematosus: results from a nationwide cohort in Spain (LESIMAB).
    Fernández-Nebro A; Marenco JL; López-Longo F; Galindo M; Hernández-Cruz BE; Narváez J; Rúa-Figueroa I; Raya-Alvarez E; Zea A; Freire M; Sánchez-Atrio AI; García-Vicuña R; Pego-Reigosa JM; Manrique-Arija S; Nieves-Martín L; Carreño L;
    Lupus; 2014 Sep; 23(10):1014-22. PubMed ID: 24833667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: a pilot study.
    Aghdassi E; Ma DW; Morrison S; Hillyer LM; Clarke S; Gladman DD; Urowitz MB; Fortin PR
    JPEN J Parenter Enteral Nutr; 2011 Mar; 35(2):198-208. PubMed ID: 21378249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-type natriuretic peptide may predict prognosis in older adults admitted with a diagnosis other than heart failure.
    Di Marca S; Rando A; Cataudella E; Pulvirenti A; Alaimo S; Terranova V; Corriere T; Pisano M; Di Quattro R; Ronsisvalle ML; Giraffa CM; Giordano M; Stancanelli B; Malatino L
    Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):636-642. PubMed ID: 29625779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of serum high-mobility group box-1 in pediatric systemic lupus erythematosus.
    Hossny E; El-Ghoneimy D; Soliman DA; Ashour A
    Int J Rheum Dis; 2019 Aug; 22(8):1402-1409. PubMed ID: 30938057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials?
    Tselios K; Gladman DD; Harvey P; Akhtari S; Su J; Urowitz MB
    J Rheumatol; 2019 Jan; 46(1):64-69. PubMed ID: 30068764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between disease onset patterns of Egyptian juvenile and adult systemic lupus erythematosus (single centre experience).
    Abdel-Nabi HH; Abdel-Noor RA
    Lupus; 2018 May; 27(6):1039-1044. PubMed ID: 29460702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of dyslipidemia in children and adolescents with systemic lupus erythematosus.
    Ardoin SP; Sandborg C; Schanberg LE
    Lupus; 2007; 16(8):618-26. PubMed ID: 17711898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence of elevated B-type natriuretic peptide levels and risk factors for heart failure in an unselected at-risk population (stage A): implications for heart failure screening programs.
    Silver MA; Pisano C
    Congest Heart Fail; 2003; 9(3):127-32. PubMed ID: 12826770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of stage A or B heart failure patients with elevated B-type natriuretic peptide levels.
    Daniels LB; Clopton P; Jiang K; Greenberg B; Maisel AS
    J Card Fail; 2010 Feb; 16(2):93-8. PubMed ID: 20142019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
    Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.